Evidence map›Paper›PMID 42756271›Full record

ArticleFrontiers in veterinary science2026

Porcine interferon-alpha but not interferon-lambda inhibits replication of genotypically diverse PRRSV isolates

Samantha J Hau, Steven G Kellner, Nickolas Knudsen, Lillian Skidmore, Peter C Canning, Susan L Brockmeier

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samantha J HauNational Animal Disease Center, ARS, USDA, Ames, IA, United States.
Steven G KellnerNational Animal Disease Center, ARS, USDA, Ames, IA, United States.
Nickolas KnudsenAmbrx, Inc., La Jolla, CA, United States.
Lillian SkidmoreAmbrx, Inc., La Jolla, CA, United States.
Peter C CanningElanco Animal Health, Greenfield, IN, United States.
Susan L BrockmeierNational Animal Disease Center, ARS, USDA, Ames, IA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Porcine reproductive and respiratory syndrome (PRRS) is an economically devastating viral infection in pigs that results in estimated losses of $1.2 billion annually. Control of porcine reproductive and respiratory syndrome virus (PRRSV) has been challenging due to the weak and delayed development of adaptive immunity to the virus. This has been partially attributed to the low induction of host interferon (IFN). IFNs are cytokines that induce an antiviral state in target cells and promote the development of the adaptive immune response to the virus. The use of exogenous IFNs are of interest in the control of PRRSV in the swine industry. Methods: The efficacy of porcine IFN-alpha (pIFNα) and porcine IFN-lambda (pIFNλ) at inhibiting PRRSV replication in porcine alveolar macrophages Results: Porcine IFNα more efficiently inhibited PRRSV replication and induced greater transcription of IFN-stimulated genes than pIFNλ; however, the efficacy of PRRSV inhibition was strain dependent. PEGylated pIFNα also reduced PRRSV replication in pretreated cells; however, the efficiency of inhibition was reduced compared to wild type pIFNα. Discussion: Porcine IFNα was shown to be more capable of inhibiting PRRSV replication; however, some strains have reduced susceptibility to pIFN treatment. This work indicates PEGylated pIFNα retains functional activity and has potential as a biotherapeutic product to control PRRSV replication in pigs.

Indexed as

antiviralinterferonporcine reproductive and respiratory syndrome virusswinetreatment

Identifiers

PMID42756271
PMCPMC13582555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.